tiprankstipranks
Invivo Therapeutics Holdings (NVIVQ)
OTHER OTC:NVIVQ
US Market

Invivo Therapeutics Holdings (NVIVQ) Stock Price & Analysis

508 Followers

NVIVQ Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.15 - $1.64
Previous Close$0.26
Volume13.61K
Average Volume (3M)3.89M
Market Cap
$807.42K
Enterprise Value-$7.77M
Total Cash (Recent Filing)$8.58M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Beta1.65
Apr 01, 2019
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-3.32
Shares Outstanding3,105,446
10 Day Avg. Volume15,025
30 Day Avg. Volume3,887,644
Standard Deviation0.25
R-Squared0.01
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)0.11
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.86
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

NVIVQ FAQ

What was Invivo Therapeutics Holdings’s price range in the past 12 months?
Invivo Therapeutics Holdings lowest stock price was $0.15 and its highest was $1.64 in the past 12 months.
    What is Invivo Therapeutics Holdings’s market cap?
    Currently, no data Available
    When is Invivo Therapeutics Holdings’s upcoming earnings report date?
    Invivo Therapeutics Holdings’s upcoming earnings report date is Apr 01, 2019 which is 1823 days ago.
      How were Invivo Therapeutics Holdings’s earnings last quarter?
      Invivo Therapeutics Holdings released its earnings results on Nov 08, 2018. The company reported -$315 earnings per share for the quarter, missing the consensus estimate of N/A by -$315.
        Is Invivo Therapeutics Holdings overvalued?
        According to Wall Street analysts Invivo Therapeutics Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Invivo Therapeutics Holdings pay dividends?
          Invivo Therapeutics Holdings does not currently pay dividends.
          What is Invivo Therapeutics Holdings’s EPS estimate?
          Invivo Therapeutics Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Invivo Therapeutics Holdings have?
          Invivo Therapeutics Holdings has 3,105,446 shares outstanding.
            What happened to Invivo Therapeutics Holdings’s price movement after its last earnings report?
            Invivo Therapeutics Holdings reported an EPS of -$315 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Invivo Therapeutics Holdings?
              Currently, no hedge funds are holding shares in NVIVQ
              ---

              Invivo Therapeutics Holdings Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Invivo Therapeutics Holdings

              Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. The company was founded by Joseph P. Vacanti, Frank M. Reynolds, and Robert Langer in January 2005 and is headquartered in Cambridge, MA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Brainstorm Cell Therapeutics
              Onconova Therapeutics
              Mesoblast
              Voyager Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis